Editorial: Statins and the "healthy user bias" in cardiac surgery

Anesthesia and Analgesia

Volumn 111, Issue 2, 2010, Pages 261-263

  Beattie, W Scott ^a,b   Wijeysundera, Duminda N ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ATORVASTATIN; COLESTYRAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN; SIMVASTATIN;

ANEMIA; ATHEROSCLEROSIS; BLOOD TRANSFUSION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORECTAL CANCER; COMMUNITY ACQUIRED PNEUMONIA; CORONARY ARTERY SURGERY; DELIRIUM; DIET RESTRICTION; DRUG DEPENDENCE; DRUG POTENCY; EDITORIAL; EPIDEMIOLOGY; EXERCISE; HEART INFARCTION; HEART PROTECTION; HEART SURGERY; HIP FRACTURE; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; INFLUENZA VACCINATION; LENGTH OF STAY; LIPID BLOOD LEVEL; MAMMOGRAPHY; MORBIDITY; MORTALITY; MOUTH HYGIENE; OBSERVER BIAS; OCCULT BLOOD; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOLOGICAL WELL BEING; SCREENING; SECONDARY PREVENTION; SMOKING CESSATION; STROKE; SURVIVAL; THROMBOCYTE ACTIVATION; TRAFFIC ACCIDENT; VENOUS THROMBOEMBOLISM; ACUTE DISEASE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; EVIDENCE BASED MEDICINE; HEALTH BEHAVIOR; HEART VALVE; KIDNEY DISEASE; LIFESTYLE; NOTE; PATIENT COMPLIANCE; PREOPERATIVE PERIOD; PUBLISHING; TREATMENT OUTCOME;

ACUTE DISEASE; BIAS (EPIDEMIOLOGY); CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HEALTH BEHAVIOR; HEART VALVES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY DISEASES; LIFE STYLE; MEDICATION ADHERENCE; PREOPERATIVE PERIOD; PUBLICATION BIAS; TREATMENT OUTCOME;

EID: 77955114396     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181e813a0     Document Type: Editorial

References (24)

1. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-364
2. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-1245
3. Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Triedewald W. Fifteen year mortality in the Coronary Drug Project patients: long term benefit with niacin. J Am Coll Cardiol 1896;8:1245-1255
4. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 205;368:1267-1278
5. Heart Protection Study Collaborative Group. Statin costeffectiveness in the United States for people at different vascular risk levels. Circ Cardiovasc Qual Outcomes 2009; 2:65-72
6. Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being. J Am Coll Cardiol 2003;42:690-697
7. Ezekowitz JA, Straus SE, Majumdar SR, McAlister FA. Stroke: strategies for primary prevention. Am Fam Physician 2003;68:2379-2386
8. Ramcharan AS, Van Stralen KJ, Snoep JD, Mantel-Teeuwisse AK, Rosendaal FR, Doggen CJ. HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis. J Thromb Haemost 2009; 7:514-520
9. Young RP, Hopkins R, Eaton TE. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence. Postgrad Med J 2009; 85:414-421
10. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006;333:999
11. Flick ED, Habel LA, Chan KA, Haque R, Quinn VP, Van Den Eeden SK, Sternfeld B, Orav EJ, Seeger JD, Quesenberry CP Jr, Caan BJ. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs 2009;69:1445-1457
12. Flick ED, Habel LA, Chan KA, Van Den Eeden SK, Quinn VP, Haque R, Orav EJ, Seeger JD, Sadler MC, Quesenberry CP Jr, Sternfeld B, Jacobsen SJ, Whitmer RA, Caan BJ. Statin use and risk of prostate cancer in the California Mens Health Study cohort. Cancer Epidemiol Biomarkers Prev 2007;16:2218-2225
13. Toh S, Hernandez-Diaz S. Statins and fracture risk. A systematic review. Pharmacoepidemiol Drug Saf 2007;16:627-640
14. Katznelson R, Djaiani GN, Borger MA, Friedman Z, Abbey SE, Fedorko L, Karski J, Mitsakakis N, Carroll J, Beattie WS. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology 2009; 110:67-73
15. Katznelson R, Djaiani G, Mitsakakis N, Lindsay TF, Tait G, Friedman Z, Wasowicz M, Beattie WS. Delirium following vascular surgery: increased incidence with preoperative betablocker administration. Can J Anaesth 2009;56:793-801
16. Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, Solomon DH. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007; 166:348-354
17. Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009;119:2051-2057
18. Rogers SL, Magliano DJ, Levison DB, Webb K, Clarke PJ, Grobler MP, Liew D. A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin. Clin Ther 2007;29:242-252
19. Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48:438-445 (Pubitemid 44109954)
20. Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther 2007;29:253-260
21. Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statinrelated adverse events: a meta-analysis. Clin Ther 2006;28: 26-35
22. Argalious M, Xu M, Sun Z, Smedira N, Koch CG. Preoperative statin therapy is not associated with a reduced incidence of postoperative acute kidney injury after cardiac surgery. Anesth Analg 2010;111:324-330
23. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007;33:409-413
24. Wijeysundera DN, Karkouti K, Dupuis JY, Rao V, Chan CT, Granton JT, Beattie WS. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007;297:1801-1809